Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.
De Luca L, Colivicchi F, Meessen J, Uguccioni M, Piscione F, Bernabò P, Lardieri G, Granatelli A, Gabrielli D, Gulizia MM; EYESHOT Post-MI Investigators. De Luca L, et al. Among authors: meessen j. Clin Cardiol. 2019 Nov;42(11):1113-1120. doi: 10.1002/clc.23262. Epub 2019 Aug 31. Clin Cardiol. 2019. PMID: 31471975 Free PMC article.
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry.
De Luca L, Arca M, Temporelli PL, Meessen J, Riccio C, Bonomo P, Colavita AR, Gabrielli D, Gulizia MM, Colivicchi F; START Investigators. De Luca L, et al. Among authors: meessen j. Int J Cardiol. 2020 Oct 1;316:229-235. doi: 10.1016/j.ijcard.2020.05.055. Epub 2020 May 26. Int J Cardiol. 2020. PMID: 32470532
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry.
De Luca L, Formigli D, Meessen J, Uguccioni M, Cosentino N, Paolillo C, Di Lenarda A, Colivicchi F, Gabrielli D, Gulizia MM, Scherillo M; START Investigators. De Luca L, et al. Among authors: meessen j. Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):513-520. doi: 10.1093/ehjqcco/qcaa054. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 32559279
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry.
Silverio A, Benvenga RM, Piscione F, Gulizia MM, Meessen JMTA, Colivicchi F, Nardi F, Baldi C, Galasso G, Vecchione C, Di Lenarda A, Gabrielli D, De Luca L. Silverio A, et al. J Cardiovasc Pharmacol Ther. 2021 Mar;26(2):149-157. doi: 10.1177/1074248420947633. Epub 2020 Aug 6. J Cardiovasc Pharmacol Ther. 2021. PMID: 32757779
External applicability of the ISCHEMIA trial: an analysis of a prospective, nationwide registry of patients with stable coronary artery disease.
De Luca L, Uguccioni M, Meessen J, Temporelli PL, Tomai F, De Rosa FM, Passamonti E, Formigli D, Riccio C, Gabrielli D, Colivicchi F, Gulizia MM, Perna GP. De Luca L, et al. Among authors: meessen j. EuroIntervention. 2020 Dec 18;16(12):e966-e973. doi: 10.4244/EIJ-D-20-00610. EuroIntervention. 2020. PMID: 32830646 Free article.
Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registry.
De Luca L, Gulizia MM, Gabrielli D, Meessen J, Mattei L, D'Urbano M, Colivicchi F, Temporelli PL, Borghi C, Desideri G; START Investigators. De Luca L, et al. Among authors: meessen j. Nutr Metab Cardiovasc Dis. 2022 Feb;32(2):393-401. doi: 10.1016/j.numecd.2021.09.034. Epub 2021 Oct 16. Nutr Metab Cardiovasc Dis. 2022. PMID: 34893417
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M, Aimo A, Vergaro G, Bayes-Genis A, Lupón J, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Gullestad L, Broch K, Ueland T, Nymo SH, Brunner-La Rocca HP, de Boer RA, Gaggin HK, Ripoli A, Passino C, Januzzi JL Jr. Emdin M, et al. Among authors: meessen j. J Am Coll Cardiol. 2018 Nov 6;72(19):2309-2320. doi: 10.1016/j.jacc.2018.08.2165. J Am Coll Cardiol. 2018. PMID: 30384887 Free article.
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome.
Aimo A, Januzzi JL Jr, Vergaro G, Clerico A, Latini R, Meessen J, Anand IS, Cohn JN, Gravning J, Ueland T, Nymo SH, Brunner-La Rocca HP, Bayes-Genis A, Lupón J, de Boer RA, Yoshihisa A, Takeishi Y, Egstrup M, Gustafsson I, Gaggin HK, Eggers KM, Huber K, Tentzeris I, Ripoli A, Passino C, Emdin M. Aimo A, et al. Among authors: meessen j. Eur J Prev Cardiol. 2019 Nov;26(16):1751-1759. doi: 10.1177/2047487319852809. Epub 2019 Jun 1. Eur J Prev Cardiol. 2019. PMID: 31154828
Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation: An Ancillary Study From the OPERA Trial.
Corradi D, Saffitz JE, Novelli D, Asimaki A, Simon C, Oldoni E, Masson S, Meessen JMTA, Monaco R, Manuguerra R, Latini R, Libby P, Tavazzi L, Marchioli R, Dozza L, Cavallotti L, Aleksova A, Gregorini R, Mozaffarian D. Corradi D, et al. Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008382. doi: 10.1161/CIRCEP.120.008382. Epub 2020 Jul 12. Circ Arrhythm Electrophysiol. 2020. PMID: 32654517 Free PMC article. Clinical Trial.
76 results